Adimab vs Theradaptive
Adimab vs Theradaptive, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adimab is on 53/100 and Theradaptive on 45/100.
Where each one leads
Adimab
- our overall score: 53/100 against 45/100
- domain rating: 39/100 against 28/100
- headcount: 139 against 31
- funding raised: $105M against $32.2M
Theradaptive
- agent readiness: 47/100 against 40/100
At a glance
| Measure | Adimab | Theradaptive |
|---|---|---|
| What it is | Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform. | Biotech company developing targeted regenerative therapeutics using a proprietary protein engineering platform for tissue repair. |
| Category | Biotech, Drug Discovery, Antibody Discovery, Therapeutic Antibodies | Biotech, Regenerative Medicine, Protein Engineering, Medical Devices |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2007 | 2017 |
| Headquarters | Lebanon, United States | Frederick, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Adimab | Theradaptive |
|---|---|---|
| Employees | 139 | 31 |
| Total funding | $105M | $32.2M |
| Latest round | Series B | Series A |
| LinkedIn followers | 8,423 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adimab | Theradaptive |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 45/100 |
| Traction | 60/100 | 53/100 |
| Search visibility | 20/100 | 2/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | D (47/100) |
| Domain ratingLink authority, 0-100 | 39/100 | 28/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adimab | Theradaptive |
|---|---|---|
| Hosting | AWS | Self Managed |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Bootstrap | Jquery, Bootstrap |
| Analytics | Google Tag Manager, Linkedin Insight | Google Analytics 4 |
| Support stack | HubSpot | Not detected |
Adimab vs Theradaptive: common questions
Which is better, Adimab or Theradaptive?
On our 0-100 score Adimab rates higher (53/100 against 45/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Adimab and Theradaptive compare on the numbers?
Adimab leads on our overall score (53/100 against 45/100), domain rating (39/100 against 28/100), headcount (139 against 31), funding raised ($105M against $32.2M). Theradaptive leads on agent readiness (47/100 against 40/100).
Read the full Adimab review and pricing or the Theradaptive review and pricing. You can also browse other Adimab alternatives we track.